Kymera Therapeutics, Inc. (KYMR) Presents At Citi's 2025 Biopharma Back To School Conference Transcript

PresentationGeoffrey MeachamManaging Director Here we go. So welcome to the second day of the Citi Biopharma, the Back to School Conference. I'm Geoff Meacham. My team is here with me as well. I'm the senior biopharma analyst. So our next session is Kymera Therapeutics. We're thrilled to have CEO, Nello Mainolfi, President and CEO, sorry; and then Jared Gollob, CMO; Justine from the IR team. Bruce may or may not be here. So maybe, Nello, thanks for joining us, by the way. ...